Hi, everyone. My name is james matheny, the new ceo and president of the Rand Corporation. A nonprofit nonpartisan Research Organization committed to the public good. This is my first public event in my new role and i am grateful that its on biodefense. This is probably the topic i lost the most sleep over the last 20 years. I expect i will be losing more sleep tonight but but i thit will be worth it. The covid 19 pendant has shown a devastating impact can be due to a moderate pandemic, and we can imagine the impact of biological threats that are either here or on the horizon that have more thann a 1 infection the county rate. The biological threats that are enabled by advances and Synthetic Biology make possible to design pathogens that are evenre more severe, that are evn more deadly than what we find in nature. The capabilities are accessible not just to state biological weapons programs that unfortunately persist today but also to individuals. To help us understand the threats we f
ICON Public Limited Company (NASDAQ:ICLR) Q3 2023 Earnings Call Transcript October 26, 2023 Kate Haven: Good day, and thank you for joining us on this call covering the quarter ended September 30, 2023. Also on the call today, we have our CEO, Dr. Steve Cutler; and our CFO, Mr. Brendan Brennan. I would like to […]
Kate Haven: Good day, and thank you for joining us on this call covering the quarter ended September 30, 2023. Also on the call today, we have our CEO, Dr. Steve Cutler; and our CFO, Mr.
By Sabela Ojea Arya Sciences Acquisition said Monday it is redeeming shares, as it won't consummate a business combination with a third party within the.
Medicus Sciences Acquisition Corp. Announces Liquidation New York, New York, February 13, 2023 - Medicus Sciences Acquisition Corp. , announced today that due to its inability. | February 13, 2023